Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.

Yoram Palti
Ashley Cordova
Chief Financial Officer
Wilco Groenhuysen
Chief Operating Officer
Ely Benaim
Chief Medical Officer
Frank Leonard
Chief Development Officer
Pritesh Shah
Chief Commercial Officer
Uri Weinberg
Chief Science Officer
Todd Longsworth
General Counsel

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.